Posted: 15 February 2023 RMIT scientists have created a new type of antibiotic that can be rapidly re-engineered to avoid resistance by dangerous superbugs. Developed by PhD candidate Priscila Cardoso and principal supervisor Dr Céline Valéry from the…
Posted: 15 February 2023 La Trobe University researchers will collaborate with several industry and university partners, to develop ‘customised exosomes’ that have the potential to treat a wide range of diseases, including traumatic brain injury and retinal disease.…
Posted: 13 February 2023 RMIT is the first Victorian university to be awarded a SAGE Cygnet Award, just the third Cygnet Award to be given nationally. The SAGE Cygnet Award has been awarded to RMIT for work to…
Posted: 13 February 2023 Research to develop and deploy a world-first diagnostic test that could accelerate malaria eradication has been bolstered with over $1.3 million in new funding from the National Health and Medical Research Council (NHMRC). Two…
Posted: 13 February 2023 Hypertension—high blood pressure—is a leading cause of death worldwide. Four out of five hypertensive patients have uncontrolled blood pressure despite clinical and lifestyle therapy, suggesting new approaches are needed. Over the past decade, experimental…
Posted: 13 February 2023 Researchers have used fruit flies to decipher an unexplained connection between Alzheimer’s disease and a genetic variation, revealing that it causes neurons to die. The findings from the WEHI-led team uncover a possible cause…
Posted: 9 February 2023 Research Panel Detects Four of the Most Common Sexually Transmitted Infectious Pathogens with One Panel Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems TrueMark STI…
Posted: 9 February 2023 Dimerix Limited a biopharmaceutical company with late-stage clinical assets in inflammatory diseases, today confirmed that an independent Data Safety Monitoring Board (DSMB) has successfully concluded a review of the ACTION3 phase 3 clinical trial.…
Posted: 9 February 2023 INOVIQ Limited is pleased to announce positive results from an independent retrospective case-control study to evaluate the performance of its SubB2M-CA15.3 breast cancer test across all stages of breast cancer. CA15.3 is a tumour…
Posted: 7 February 2023 A cancer research team, led by Doherty Institute Associate Professor Theo Mantamadiotis, Head of the Brain Cancer Molecular Biology Lab at the University of Melbourne, is working to decipher the molecular and cellular mechanisms…
Posted: 7 February 2023 Closes: 28 April, 5pm (if places are not filled earlier). ARCS Australia is offering a careers day on Thursday 8 June as part of the 2023 ARCS Annual Conference. The conference is widely regarded as…
Posted: 7 February 2023 Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune diseases, today announces the investigator-initiated INSIGHT-003 trial has reached its enrolment target of 20 patients with 1L NSCLC. INSIGHT-003 is…